Superorganism, a venture capital firm focused exclusively on biodiversity, has closed its first fund with $25.9 million in capital commitments, marking a rare institutional push into nature-positive investing at the early-stage level.

Founded in 2023, Superorganism positions itself as the first VC firm designed to act as a conservation-focused partner on the cap table of startups working to protect ecosystems, slow species loss, and rebuild natural systems. The fund attracted backing from institutional and strategic investors including Cisco Foundation, Builders Vision, AMB Holdings, and several individual investors, including Jeff Jordan.

 

Biodiversity as an Investable System Risk

 

Superorganism’s strategy mirrors climate venture investing but applies the same logic to nature loss. Rather than focusing on carbon emissions alone, the firm targets technologies that directly address biodiversity decline, ecosystem degradation, and the growing regulatory and economic risks associated with nature loss.

Kevin Webb, managing director at Superorganism, described the approach as applying climate-tech thinking to biodiversity, with the goal of reducing nature loss in the same way climate startups aim to reduce emissions.

The fund invests at the pre-seed and seed stages, typically writing checks between $250,000 and $500,000, and has committed to donating 10 percent of its profits to future conservation initiatives.

 

Read more: Energy Firms Raise $870.8 Million Green Bond to Refinance UAE’s Al Dhafra Solar Project

 

Investment Focus Across Three Biodiversity Frontiers

 

Superorganism backs companies operating across three core areas: technologies that slow or reverse species extinction, businesses at the intersection of climate and biodiversity, and tools that improve the effectiveness of conservation work itself.

One example is portfolio company Spoor, which uses computer vision to track bird movement and migration patterns near wind farms. By helping developers reduce bird collisions and regulatory risk, the technology aligns biodiversity protection with renewable energy deployment, demonstrating how nature-positive solutions can also unlock commercial value.

The firm’s broader portfolio spans multiple industries and technology types, a deliberate strategy to reduce exposure to sector-specific or political volatility.

 

Building a Diversified, Resilient Nature Portfolio

 

Co-founder and managing director Tom Quigley said the firm has intentionally built a diversified portfolio to demonstrate what scalable biodiversity businesses can look like across different markets. Rather than concentrating on a single vertical, Superorganism aims to create a reference portfolio that shows biodiversity innovation can generate returns while delivering measurable ecological outcomes.

This diversification has also helped the firm navigate shifting political dynamics around climate and environmental policy in the United States. Quigley noted that many biodiversity challenges, such as invasive species management or ecosystem restoration, often cut across partisan divides.

He cited portfolio company Inversa, which converts invasive species into leather goods, as an example of a biodiversity solution that has received support across the political spectrum, including recognition from Florida’s state government.

 

Explore OneStop ESG Marketplace: Carbon offset services

 

Fund Progress and Forward Outlook

 

To date, Superorganism has invested in 20 companies and plans to build a final portfolio of approximately 35 startups from its first fund. The firm sees its role not only as a capital provider but also as a market-builder, helping other investors gain confidence in biodiversity as an investable asset class.

Quigley said the firm recognises its position as an early mover and aims to bring additional capital into the space by demonstrating that biodiversity-focused companies can be commercially viable, scalable, and resilient across policy cycles.

As nature-related risks increasingly move onto regulatory, corporate, and investor agendas through frameworks such as TNFD, Superorganism’s fund signals a growing shift toward treating biodiversity loss not as a peripheral ESG issue, but as a core economic and systemic risk demanding venture-scale solutions.